NMDAR antagonist 5 (Compound A17) is a multi-target antagonist against NMDAR and monoamine transporters ( SERT 、 DAT and NET ). NMDAR antagonist 5 shows good NMDAR antagonistic potency ( IC 50 = 0.3 μM) and monoamine transporter activities (SERT IC 50 = 1.1 μM、DAT IC 50 = 0.7 μM、NET IC 50 = 2.7 μM). NMDAR antagonist 5 is highly safe and has low toxicity (hepatotoxicity and nephrotoxicity (IC 50 > 100 μM); cardiotoxicity (IC 50 = 24.5 μM)). NMDAR antagonist 5 has antidepressant effects and can be used in the study of depression.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > iGluR | Products > Signaling Pathways > Monoamine Transporter | Products > Signaling Pathways > Serotonin Transporter | Products > Signaling Pathways > Dopamine Transporter
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.